ZYUS Stock Overview
Manufactures and distributes phyto-therapeutic compounds and cannabis-based medicines in Canada and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
ZYUS Life Sciences Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$1.10 |
52 Week High | CA$1.41 |
52 Week Low | CA$0.71 |
Beta | 0 |
1 Month Change | 10.00% |
3 Month Change | 8.91% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -4.35% |
Recent News & Updates
Shareholder Returns
ZYUS | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 4.8% | 1.7% | 1.1% |
1Y | n/a | 64.6% | 10.8% |
Return vs Industry: Insufficient data to determine how ZYUS performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ZYUS performed against the Canadian Market.
Price Volatility
ZYUS volatility | |
---|---|
ZYUS Average Weekly Movement | 7.1% |
Pharmaceuticals Industry Average Movement | 14.4% |
Market Average Movement | 8.9% |
10% most volatile stocks in CA Market | 17.8% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ZYUS has not had significant price volatility in the past 3 months.
Volatility Over Time: ZYUS's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1944 | n/a | Brent Zettl | www.zyus.com |
ZYUS Life Sciences Corporation manufactures and distributes phyto-therapeutic compounds and cannabis-based medicines in Canada and internationally. The company offers cannabinoid-based therapeutics and products, such as oils, gel-caps, and topical creams. ZYUS Life Sciences Corporation was incorporated in 1944 and is based in Saskatoon, Canada.
ZYUS Life Sciences Corporation Fundamentals Summary
ZYUS fundamental statistics | |
---|---|
Market cap | CA$73.68m |
Earnings (TTM) | -CA$42.59m |
Revenue (TTM) | CA$351.00k |
222.0x
P/S Ratio-1.8x
P/E RatioIs ZYUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZYUS income statement (TTM) | |
---|---|
Revenue | CA$351.00k |
Cost of Revenue | CA$2.36m |
Gross Profit | -CA$2.01m |
Other Expenses | CA$40.58m |
Earnings | -CA$42.59m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.60 |
Gross Margin | -572.65% |
Net Profit Margin | -12,134.19% |
Debt/Equity Ratio | 29.4% |
How did ZYUS perform over the long term?
See historical performance and comparison